Stocktoria

Cytosorbents Corp CTSO

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2005-06-17 · LEI

Cytosorbents Corp statistics & valuation

Market cap$22.7M
P / S0.6×
P / B3.9×
Net margin-22.1%
Return on equity-138.9%
FCF margin-33.8%
Net debt$10.4M
Enterprise value USD$33.2M
Earnings yield EBIT/EV-44.5%
Return on capital-42.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-123.50% -55.80% -76.50% -77.20% -19.10% -56.90% -94.60% -94.10% -58.20% -22.10% 2016201720182019202020212022202320242025
Gross margin (%)
58.50% 63.60% 66.70% 70.50% 73.00% 74.40% 59.80% 70.60% 69.90% 71.50% 2016201720182019202020212022202320242025
Operating margin (%)
-120.60% -65.00% -69.30% -76.00% -25.30% -52.70% -90.90% -102.80% -46.20% -39.80% 2016201720182019202020212022202320242025
Return on equity (%)
-879.50% -82.40% -101.60% -563.60% -9.90% -39.20% -92.80% -124.60% -186.50% -138.90% 2016201720182019202020212022202320242025
Shares outstanding
25.5M 29.0M 31.8M 32.6M 43.2M 43.6M 43.6M 54.2M 54.8M 62.8M 2016201720182019202020212022202320242025
Net debt ($)
-$333531 -$7.3M -$12.4M $2.8M -$71.4M -$17.1M -$9.1M $10.7M $10.4M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-121.30% -35.10% -50.30% -70.40% -8.70% -27.40% -51.90% -55.20% -43.70% -18.60% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-72.10% -49.20% -51.20% -70.00% -15.40% -40.90% -98.90% -71.40% -41.30% -33.80% 2016201720182019202020212022202320242025
Debt / equity (×)
3.67× 0.97× 0.59× 4.40× 0.00× 0.14× 0.21× 1.26× 2.82× 2016201720182019202020212022202320242025
EPS ($)
-$0.60 -$0.20 -$0.57 -$0.75 -$0.65 -$0.38 -$0.13 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin71.5%69.9%70.6%59.8%74.4%73.0%70.5%66.7%63.6%58.5%
Operating margin-39.8%-46.2%-102.8%-90.9%-52.7%-25.3%-76.0%-69.3%-65.0%-120.6%
Net margin-22.1%-58.2%-94.1%-94.6%-56.9%-19.1%-77.2%-76.5%-55.8%-123.5%
FCF margin-33.8%-41.3%-71.4%-98.9%-40.9%-15.4%-70.0%-51.2%-49.2%-72.1%
Return on assets-18.6%-43.7%-55.2%-51.9%-27.4%-8.7%-70.4%-50.3%-35.1%-121.3%
Return on equity-138.9%-186.5%-124.6%-92.8%-39.2%-9.9%-563.6%-101.6%-82.4%-879.5%
Debt / equity2.82×1.26×0.21×0.14×—0.00×4.40×0.59×0.97×3.67×
Current ratio2.132.201.813.484.708.122.104.092.641.83

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.